Journey Medical Corporation (DERM) Company Report Jan. 21, 2023, 00:05 UTC 59 Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer Comment Full text
QuantumSi Inc (QSI) Company Report Jan. 19, 2023, 01:20 UTC 65 New Form 4 for Quantum-Si Incorporated Comment Full text
Lexaria Bioscience Corp. (LEXX) Company Report Jan. 19, 2023, 00:30 UTC 60 New SEC Form for Lexaria Bioscience Corp. Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Company Report Jan. 18, 2023, 16:10 UTC 66 National Comprehensive Cancer Network® Adds Newly Approved REZLIDHIA™ (olutasidenib) to Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia Comment Full text
Lexaria Bioscience Corp. (LEXX) Company Report Jan. 18, 2023, 00:55 UTC 59 New SEC Form for Lexaria Bioscience Corp. Comment Full text
MAIA Biotechnology Inc. (MAIA) Company Report Jan. 17, 2023, 19:52 UTC 53 MAIA The Next Generation is Here - New Molecular Candidates Comment Full text
Mustang Bio Inc (MBIO) Company Report Jan. 17, 2023, 16:20 UTC 56 Mustang Bio to Participate in the B. RileySecurities’ 3rd Annual Oncology Conference Comment Full text
MAIA Biotechnology Inc. (MAIA) Company Report Jan. 15, 2023, 17:52 UTC 60 MAIA participates in 4 Investor Conferences. A strong start to the New Year. Comment Full text
Relmada Therapeutics Inc (RLMD) Company Report Jan. 12, 2023, 20:30 UTC 59 Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors Comment Full text
QuantumSi Inc (QSI) Company Report Jan. 12, 2023, 16:05 UTC 55 New Form 8-K for Quantum-Si Incorporated Comment Full text